A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose Finding Study to Assess the Safety and Effectiveness of Tovinontrine in Patients With Chronic Heart Failure With Reduced Ejection Fraction.
Datos básicos
Documentos
- No hay documentos
Participantes
Grupos
Financiadores - Promotores
CARDURION PHARMACEUTICALS INC.
Portal de investigación